ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.109,16
0,20%
S&P 500
5.473,23
0,00%
Dow Jones
38.778,10
0,00%
Euro vs US Dollar
1,07123
-0,26%
Bitcoin
65.131,46
-2,04%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

POLB

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:POLB
DatumZeitQuelleÜberschriftSymbolFirma
17/06/202409h38RNS Regulatory NewsPoolbeg Pharma PLC Result of AGMLSE:POLBPoolbeg Pharma Plc
09/05/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Annual Report & AGM NoticeLSE:POLBPoolbeg Pharma Plc
01/05/202417h39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202417h39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202417h30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202417h30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202408h02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202408h01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202408h00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202417h18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202417h18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202408h00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202414h42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202417h02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202417h02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Board Role Change and Launch of EIPLSE:POLBPoolbeg Pharma Plc
12/02/202420h44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202420h44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRSLSE:POLBPoolbeg Pharma Plc
17/01/202414h58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202414h58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202408h00UK RegulatoryPoolbeg Pharma PLC Further data shows POLB001 potential in cancer CRSLSE:POLBPoolbeg Pharma Plc
20/12/202321h00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202321h00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202308h00UK RegulatoryPoolbeg Pharma PLC RSV AI Drug Candidate Analysis UpdateLSE:POLBPoolbeg Pharma Plc
11/12/202308h00UK RegulatoryPoolbeg Pharma PLC POLB 001 Data Presented at ASHLSE:POLBPoolbeg Pharma Plc
30/11/202308h00UK RegulatoryPoolbeg Pharma PLC Directorate ChangeLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Kürzlich von Ihnen besucht

ASX
STWSON
NASDAQI
SX402040GI
OMX Stockholm Personal G...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten